Healthcare provider profile · identity verified

John Mark Beard, MD

Family Practice · MUKILTEO, WA · NPI 1225118201

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	323	83
Atorvastatin Calcium	Atorvastatin Calcium	292	90
Lisinopril	Lisinopril	284	87
Amlodipine Besylate	Amlodipine Besylate	222	66
Losartan Potassium	Losartan Potassium	210	65
Gabapentin	Gabapentin	169	41
Omeprazole	Omeprazole	159	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	158	29
Metoprolol Succinate	Metoprolol Succinate	154	51
Tamsulosin Hcl	Tamsulosin Hcl	146	49
Eliquis	Apixaban	138	29
Furosemide	Furosemide	133	43
Sertraline Hcl	Sertraline Hcl	117	30
Simvastatin	Simvastatin	117	37
Metformin Hcl	Metformin Hcl	115	34
Hydrochlorothiazide	Hydrochlorothiazide	110	34
Albuterol Sulfate Hfa	Albuterol Sulfate	106	35
Duloxetine Hcl	Duloxetine Hcl	106	25
Trazodone Hcl	Trazodone Hcl	101	29
Oxycodone Hcl	Oxycodone Hcl	99	17
Potassium Chloride	Potassium Chloride	99	32
Rosuvastatin Calcium	Rosuvastatin Calcium	98	30
Pantoprazole Sodium	Pantoprazole Sodium	86	18
Lovastatin	Lovastatin	83	21
Allopurinol	Allopurinol	80	21
Lorazepam	Lorazepam	80	16
Tizanidine Hcl	Tizanidine Hcl	78	15
Carvedilol	Carvedilol	62	19
Tramadol Hcl	Tramadol Hcl	59	13
Pravastatin Sodium	Pravastatin Sodium	57	15
Spironolactone	Spironolactone	55	20
Meloxicam	Meloxicam	53	15
Escitalopram Oxalate	Escitalopram Oxalate	50	12
Warfarin Sodium	Warfarin Sodium	50	11
Clonazepam	Clonazepam	48	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Xarelto	Rivaroxaban	45	12
Oxybutynin Chloride	Oxybutynin Chloride	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	42	19
Metoprolol Tartrate	Metoprolol Tartrate	42	suppressed
Montelukast Sodium	Montelukast Sodium	41	13
Buspirone Hcl	Buspirone Hcl	40	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	suppressed
Mirtazapine	Mirtazapine	39	suppressed
Ozempic	Semaglutide	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Jardiance	Empagliflozin	36	suppressed
Symbicort	Budesonide/Formoterol Fumarate	35	suppressed
Atenolol	Atenolol	34	suppressed
Famotidine	Famotidine	34	13
Metformin Hcl Er	Metformin Hcl	34	14
Prednisone	Prednisone	34	14
Fluoxetine Hcl	Fluoxetine Hcl	33	12
Arnuity Ellipta	Fluticasone Furoate	32	suppressed
Estradiol	Estradiol	32	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	11
Triamcinolone Acetonide	Triamcinolone Acetonide	30	16
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	11
Bupropion Xl	Bupropion Hcl	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Topiramate	Topiramate	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Finasteride	Finasteride	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	12
Synthroid	Levothyroxine Sodium	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Nurtec Odt	Rimegepant Sulfate	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Nitroglycerin	Nitroglycerin	17	11
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	15
Acyclovir	Acyclovir	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Lactulose	Lactulose	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Clomipramine Hcl	Clomipramine Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Azathioprine	Azathioprine	11	suppressed
Diazepam	Diazepam	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Klor-Con 10	Potassium Chloride	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error